Lv11
38 积分 2023-04-11 加入
Inhibitors of Bruton's tyrosine kinase as emerging therapeutic strategy in autoimmune diseases
5小时前
待确认
The clinical KRAS(G12C) inhibitor AMG 510 drives anti-tumour immunity
2个月前
已完结
Bispecific anti-CD20, anti-CD19 CAR T cells for relapsed B cell malignancies: a phase 1 dose escalation and expansion trial
3个月前
已完结
Discovery and Preclinical Pharmacology of NX-2127, an Orally Bioavailable Degrader of Bruton’s Tyrosine Kinase with Immunomodulatory Activity for the Treatment of Patients with B Cell Malignancies
5个月前
已完结
Development of a clinically relevant ovarian cancer model incorporating surgical cytoreduction to evaluate treatment of micro-metastatic disease
7个月前
已完结
In vivo and in vitro inhibition of SCLC by combining dual cancer-specific recombinant adenovirus with Etoposide
7个月前
已完结
High frequency of alternative splicing variants of the oncogene Focal Adhesion Kinase in neuroendocrine tumors of the pancreas and breast
7个月前
已完结
Preclinical efficacy of RAF/MEK clamp avutometinib in combination with FAK inhibition in low grade serous ovarian cancer
8个月前
已完结
Differentiating Ensartinib from Lorlatinib and Alectinib for first line use in an ALK+ non-small cell lung cancer preclinical model (ResCu)
11个月前
已完结
FAK in cancer: mechanistic findings and clinical applications
1年前
已完结
皖公网安备34019202002308
